TELMIKAA CT (Telmisartan (40mg) + Chlorthalidone (12.5mg))

Telmikaa CT Tablet is formulated with two active ingredients that work collaboratively to manage hypertension. Effectively lowering blood pressure is crucial as it significantly reduces the likelihood of experiencing cardiovascular events such as strokes and heart attacks in the future. This medication can be ingested with or without food, depending on your preference or doctor’s guidance. The prescribed dosage will be tailored to your specific health condition and individual response to treatment. It is advisable to administer this tablet consistently at the same time daily to maintain stable blood pressure levels. Continuing the medication as directed by your healthcare provider is essential, even if you feel stable and well, since hypertension often presents without noticeable symptoms. Sudden discontinuation can elevate your risk for serious health complications. One of the primary side effects experienced with this medication is dizziness. While frequent urination is an expected effect of chlorthalidone, which is an ingredient in this formulation, it is not categorized as a side effect per se. Other potential adverse reactions may include nausea, diarrhea, headaches, and changes in lipid levels. Reading the accompanying medication guide is crucial to understand the possible side effects thoroughly, and any persistent or troubling side effects should be communicated to your doctor for possible dosage adjustments or consideration of alternative treatments. This medication is not advisable for use during pregnancy, and prior consultation with your doctor is necessary if you have existing kidney or liver issues, heart conditions, or diabetes. Additionally, the consumption of alcohol may exacerbate blood pressure reduction and lead to adverse effects.